Cellebrite Announces Participation in Upcoming Investor Conferences
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in […]
Ascent Solar Collaborates with University of Stuttgart IGTE for the Development and Distribution of Sustainable Power Generation Technology
THORNTON, Colo., May 16, 2024 (GLOBE NEWSWIRE) — Ascent Solar Technologies, (Nasdaq: ASTI) (“Ascent” or the “Company”), the leading U.S. […]
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
ATHENS, Greece, May 16, 2024 (GLOBE NEWSWIRE) — IMPERIAL PETROLEUM INC. (NASDAQ: IMPP, the “Company”), a ship-owning company providing petroleum […]
Regency Centers Releases Annual Corporate Responsibility Report for 2023
JACKSONVILLE, Fla., May 16, 2024 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency”, “Regency Centers” or the “Company”) (Nasdaq:REG) today released […]
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
SANTA ANA, Calif., May 16, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage […]
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. […]
Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical […]
CCSC Technology International Holdings Limited Announces Plan for New Supply Chain Management Center in Central Europe
Hong Kong, May 16, 2024 (GLOBE NEWSWIRE) — CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a […]
Arq Announces $15 Million PIPE Transaction
Entered Into $15 million PIPE at $7.00 per share, reflecting a roughly 3% discount to yesterday’s close Transaction resulted from […]
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
Development of BIIB105, an investigational antisense oligonucleotide for amyotrophic lateral sclerosis (ALS), will be discontinued based on data from the […]
